BH
The startup develops drugs aimed at enhancing human performance and longevity through computational drug design and bioinformatics. By utilizing predictive in vitro assays, the company provides pharmaceutical clients with data-driven insights for identifying relevant bio-molecular targets for novel therapeutic compounds.
Updated 3 months ago
Funding
$6.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops drugs aimed at enhancing human performance and longevity through computational drug design and bioinformatics. By utilizing predictive in vitro assays, the company provides pharmaceutical clients with data-driven insights for identifying relevant bio-molecular targets for novel therapeutic compounds.